2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 892 | 3.448 | 26.666 | - | 20.333 | - | 15.527 | 39.934 | 38.772 | 39.494 |
Total Income - EUR | 892 | 3.448 | 26.666 | - | 20.333 | - | 15.527 | 39.934 | 38.772 | 39.494 |
Total Expenses - EUR | 1.393 | 3.013 | 12.881 | - | 20.487 | - | 11.974 | 14.204 | 23.967 | 28.728 |
Gross Profit/Loss - EUR | -500 | 435 | 13.786 | - | -155 | - | 3.554 | 25.730 | 14.805 | 10.766 |
Net Profit/Loss - EUR | -527 | 332 | 13.149 | - | -358 | - | 3.522 | 25.331 | 14.442 | 10.370 |
Employees | 1 | 1 | 1 | - | 0 | - | 2 | 2 | 2 | 0 |
Check the financial reports for the company - Fil Ştefmed Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 0 | - | 0 | - | 0 | 0 | 0 | 0 |
Current Assets | 708 | 4.364 | 17.541 | - | 10.978 | - | 15.745 | 41.140 | 55.702 | 66.851 |
Inventories | 0 | 124 | 122 | - | 336 | - | 324 | 316 | 317 | 316 |
Receivables | 0 | 2.867 | 2.838 | - | 10.410 | - | 10.412 | 2.861 | 2.870 | 2.862 |
Cash | 708 | 1.373 | 14.581 | - | 231 | - | 5.010 | 37.962 | 52.514 | 63.673 |
Shareholders Funds | -483 | -155 | 12.995 | - | 9.706 | - | 15.273 | 40.265 | 54.832 | 65.037 |
Social Capital | 45 | 45 | 0 | - | 43 | - | 41 | 40 | 41 | 40 |
Debts | 1.191 | 4.520 | 4.546 | - | 1.272 | - | 472 | 875 | 869 | 1.814 |
Income in Advance | 0 | 0 | 0 | - | 0 | - | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7500 - 7500" | |||||||||
CAEN Financial Year |
7500
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Fil Ştefmed Srl